Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen
Titel:
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen
Auteur:
Sendur, Mehmet Ali Nahit Ozdemir, Nuriye Özatlı, Tahsin Yazıcı, Ozan Aksoy, Sercan Ekinci, Ahmet Şiyar Yazılıtaş, Doğan Günaydın, Yusuf Oksuzoglu, Berna Benekli, Mustafa Zengin, Nurullah